|
|
||||||||
AJP - Renal Physiology, Vol 273, Issue 5 706-F711, Copyright © 1997 by American Physiological Society
ARTICLES |
T. Terada, H. Saito, M. Mukai and K. Inui
Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University, Japan.
PEPT1 and PEPT2 are H(+)-coupled peptide transporters expressed preferentially in the intestine and kidney, respectively, which mediate uphill transport of oligopeptides and peptide-like drugs such as beta-lactam antibiotics. In the present study, we have compared the recognition of beta-lactam antibiotics by LLC-PK1 cells stably transfected with PEPT1 or PEPT2 cDNA. Cyclacillin (aminopenicillin) and ceftibuten (anionic cephalosporin without an alpha-amino group) showed potent inhibitory effects on the glycylsarcosine uptake in the PEPT1-expressing cells. Other beta-lactams, such as cephalexin, cefadroxil, and cephradine (aminocephalosporins), inhibited modestly the PEPT1-mediated glycylsarcosine uptake. Except for ceftibuten, these beta-lactams showed much more potent inhibitions on the glycylsarcosine uptake via PEPT2 than via PEPT1. Comparison of the inhibition constant (Ki) values between cefadroxil and cephalexin suggested that the hydroxyl group at the NH2-terminal phenyl ring increased affinity for both PEPT1 and PEPT2. It is concluded that PEPT2 has a much higher affinity for beta-lactam antibiotics having an alpha-amino group than PEPT1 and that substituents at the NH2-terminal side chain of these drugs are involved in the recognition by both peptide transporters.
This article has been cited by other articles:
![]() |
J. Shimakura, T. Terada, H. Saito, T. Katsura, and K.-i. Inui Induction of intestinal peptide transporter 1 expression during fasting is mediated via peroxisome proliferator-activated receptor {alpha} Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G851 - G856. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tsuda, T. Terada, M. Irie, T. Katsura, A. Niida, K. Tomita, N. Fujii, and K.-i. Inui Transport Characteristics of a Novel Peptide Transporter 1 Substrate, Antihypotensive Drug Midodrine, and Its Amino Acid Derivatives J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 455 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mizuno, T. Niwa, Y. Yotsumoto, and Y. Sugiyama Impact of Drug Transporter Studies on Drug Discovery and Development Pharmacol. Rev., September 1, 2003; 55(3): 425 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Irie, T. Terada, K. Sawada, H. Saito, and K.-I. Inui Recognition and Transport Characteristics of Nonpeptidic Compounds by Basolateral Peptide Transporter in Caco-2 Cells J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 711 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Terada, K. Sawada, T. Ito, H. Saito, Y. Hashimoto, and K.-I. Inui Functional expression of novel peptide transporter in renal basolateral membranes Am J Physiol Renal Physiol, November 1, 2000; 279(5): F851 - F857. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. M. H. Van Aubel, R. Masereeuw, and F. G. M. Russel Molecular pharmacology of renal organic anion transporters Am J Physiol Renal Physiol, August 1, 2000; 279(2): F216 - F232. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Fang, W. N. Konings, and B. Poolman Kinetics and Substrate Specificity of Membrane-Reconstituted Peptide Transporter DtpT of Lactococcus lactis J. Bacteriol., May 1, 2000; 182(9): 2530 - 2535. [Abstract] [Full Text] |
||||
![]() |
K. Sawada, T. Terada, H. Saito, Y. Hashimoto, and K.-I. Inui Recognition of L-Amino Acid Ester Compounds by Rat Peptide Transporters PEPT1 and PEPT2 J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 705 - 709. [Abstract] [Full Text] |
||||
![]() |
T. Terada, K. Sawada, H. Saito, Y. Hashimoto, and K.-I. Inui Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2 Am J Physiol Gastrointest Liver Physiol, June 1, 1999; 276(6): G1435 - G1441. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iseki, M. Sugawara, K. Sato, I. Naasani, T. Hayakawa, M. Kobayashi, and K. Miyazaki Multiplicity of the H+-Dependent Transport Mechanism of Dipeptide and Anionic beta -Lactam Antibiotic Ceftibuten in Rat Intestinal Brush-Border Membrane J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 66 - 71. [Abstract] [Full Text] |
||||
![]() |
U. Wenzel, D. Diehl, M. Herget, and H. Daniel Endogenous expression of the renal high-affinity H+-peptide cotransporter in LLC-PK1 cells Am J Physiol Cell Physiol, December 1, 1998; 275(6): C1573 - C1579. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takahashi, N. Nakamura, T. Terada, T. Okano, T. Futami, H. Saito, and K.-I. Inui Interaction of beta -Lactam Antibiotics with H+/Peptide Cotransporters in Rat Renal Brush-Border Membranes J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 1037 - 1042. [Abstract] [Full Text] |
||||
![]() |
T. Terada, H. Saito, and K.-i. Inui Interaction of beta -Lactam Antibiotics with Histidine Residue of Rat H+/Peptide Cotransporters, PEPT1 and PEPT2 J. Biol. Chem., March 6, 1998; 273(10): 5582 - 5585. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |